Literature DB >> 34847342

Canadian Urological Association best practice report: Bone health in prostate cancer.

Luke T Lavallée1, Ryan McLarty1, Christopher Tran2, Rodney H Breau1, Patrick Richard3, Bobby Shayegan4, Brita Danielson5, Marie-Paul Jammal6, Fred Saad7.   

Abstract

Entities:  

Year:  2021        PMID： 34847342      PMCID： PMC8631854          DOI： 10.5489/cuaj.7660

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  60 in total

1.  2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary.

Authors:  Alexandra Papaioannou; Suzanne Morin; Angela M Cheung; Stephanie Atkinson; Jacques P Brown; Sidney Feldman; David A Hanley; Anthony Hodsman; Sophie A Jamal; Stephanie M Kaiser; Brent Kvern; Kerry Siminoski; William D Leslie
Journal:  CMAJ       Date:  2010-10-12       Impact factor: 8.262

2.  American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update.

Authors:  Salvatore L Ruggiero; Thomas B Dodson; Leon A Assael; Regina Landesberg; Robert E Marx; Bhoomi Mehrotra
Journal:  J Oral Maxillofac Surg       Date:  2009-05       Impact factor: 1.895

3.  Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment.

Authors:  E S Siris; P D Miller; E Barrett-Connor; K G Faulkner; L E Wehren; T A Abbott; M L Berger; A C Santora; L M Sherwood
Journal:  JAMA       Date:  2001-12-12       Impact factor: 56.272

4.  Hip fracture, mortality risk, and cause of death over two decades.

Authors:  M von Friesendorff; F E McGuigan; A Wizert; C Rogmark; A H Holmberg; A D Woolf; K Akesson
Journal:  Osteoporos Int       Date:  2016-05-12       Impact factor: 4.507

5.  Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial.

Authors:  Andrew L Himelstein; Jared C Foster; James L Khatcheressian; John D Roberts; Drew K Seisler; Paul J Novotny; Rui Qin; Ronald S Go; Stephen S Grubbs; Tracey O'Connor; Mario R Velasco; Douglas Weckstein; Ann O'Mara; Charles L Loprinzi; Charles L Shapiro
Journal:  JAMA       Date:  2017-01-03       Impact factor: 56.272

6.  Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer.

Authors:  Matthew R Smith; James Eastham; Donald M Gleason; Daniel Shasha; Simon Tchekmedyian; Norman Zinner
Journal:  J Urol       Date:  2003-06       Impact factor: 7.450

7.  Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases.

Authors:  F Saad; J E Brown; C Van Poznak; T Ibrahim; S M Stemmer; A T Stopeck; I J Diel; S Takahashi; N Shore; D H Henry; C H Barrios; T Facon; F Senecal; K Fizazi; L Zhou; A Daniels; P Carrière; R Dansey
Journal:  Ann Oncol       Date:  2011-10-10       Impact factor: 32.976

8.  Estrogen Regulates Bone Turnover by Targeting RANKL Expression in Bone Lining Cells.

Authors:  Carmen Streicher; Alexandra Heyny; Olena Andrukhova; Barbara Haigl; Svetlana Slavic; Christiane Schüler; Karoline Kollmann; Ingrid Kantner; Veronika Sexl; Miriam Kleiter; Lorenz C Hofbauer; Paul J Kostenuik; Reinhold G Erben
Journal:  Sci Rep       Date:  2017-07-25       Impact factor: 4.379

9.  Evaluation of Fall and Fracture Risk Among Men With Prostate Cancer Treated With Androgen Receptor Inhibitors: A Systematic Review and Meta-analysis.

Authors:  Zin W Myint; Harry D Momo; Danielle E Otto; Donglin Yan; Peng Wang; Jill M Kolesar
Journal:  JAMA Netw Open       Date:  2020-11-02

Review 10.  Bone health management in the continuum of prostate cancer disease: a review of the evidence with an expert panel opinion.

Authors:  Daniele Santini; Alfredo Berruti; Massimo Di Maio; Giuseppe Procopio; Sergio Bracarda; Toni Ibrahim; Francesco Bertoldo
Journal:  ESMO Open       Date:  2020-03
View more
  2 in total

1.  Implementing and Evaluating the Impact of BoneRx: A Healthy Bone Prescription for Men with Prostate Cancer Initiating Androgen Deprivation Therapy.

Authors:  Jennifer M Jones; Derek S Tsang; Shiyu Zheng; Ariel Yeheskel; Charles N Catton; Angela M Cheung; Robert Hamilton; Shabbir M H Alibhai
Journal:  J Clin Med       Date:  2022-05-11       Impact factor: 4.964

2.  Safety and Efficacy of Carbon-Ion Radiotherapy for Elderly Patients with High-Risk Prostate Cancer.

Authors:  Yuichi Hiroshima; Hitoshi Ishikawa; Yuma Iwai; Masaru Wakatsuki; Takanobu Utsumi; Hiroyoshi Suzuki; Koichiro Akakura; Masaoki Harada; Hideyuki Sakurai; Tomohiko Ichikawa; Hiroshi Tsuji
Journal:  Cancers (Basel)       Date:  2022-08-19       Impact factor: 6.575
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.